Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective

By Altamura A.C.   Armadoros D.   Jaeger M.   Kernish R.   Locklear J.   Volz H.-P.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2271-2282

Informa Healthcare

Access to resources Recommend Favorite

Atypical Presentation of Tardive Dyskinesia Associated with Risperidone Long-Acting Injection as Maintenance Treatment in Bipolar Affective Disorder: A Case Report

By  

Current Drug Safety, Vol. 7, Iss. 1, 2012-02 ,pp. : 21-23

Bentham Science Publishers

Access to resources Recommend Favorite

Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics

By Lafeuille Marie-Hélène   Gravel Jonathan   Lefebvre Patrick   Fastenau John   Muser Erik   Doshi Dilesh   Duh Mei Sheng  

Journal of Medical Economics, Vol. 16, Iss. 11, 2013-11 ,pp. : 1290-1299

Informa Healthcare

Access to resources Recommend Favorite

Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 17, Iss. 1, 2015-02 ,pp. : 86-96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment patterns and associated costs for genital warts in Italy

By Merito M.   Largeron N.   Cohet C.   Timelli L.   Boselli F.   Matteelli A.   Naldi L.   Vittori G.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3175-3183

Informa Healthcare

Access to resources Recommend Favorite